Temsirolimus Kit
Product Images NDC 65219-200

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Temsirolimus (NDC 65219-200). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Fresenius Kabi Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Tem07 0001 01)

FDA Label Image

Figure (Tem07 0001 02)

FDA Label Image

Fresenius Kabi Logo (Tem07 0001 03)

FDA Label Image

Principal Display Panel – 25 mg/ml Per Vial* (Carton)

Principal Display Panel – 25 mg/ml Per Vial* (Carton)
Temsirolimus Injection is a concentrated intravenous infusion solution. It comes in a single-dose vial with 0.2 mL overfill, and requires two dilutions before administration. Each carton comes with one vial of 25 mg/mL Temsirolimus Injection, a vial of diluent, and refrigeration is required. Temsirolimus Injection contains 25gL of Temsirolimus and other chemicals such as dehydrated alcohol, butylene glycol, and citric acid. Diluent for Temsirolimus Inection has polysorbate B0, PEG 40, and dehydrated alcohol. The package insert should be referred for instructions and recommended dosages. It is photographed that this product was manufactured in India.*
FDA Label Image

Principal Display Panel – 25 mg/ml Per Vial* (Vial Label)

Principal Display Panel – 25 mg/ml Per Vial* (Vial Label)
This is a description of a medicine in a single dose vial for intravenous infusion. The vial contains 0.2 mL of a substance that must be diluted before use. The concentration after dilution is 10 mg/mL. The vial should be refrigerated and used in a sterile environment. The vial contains dehydrated alcohol and emsirolimus injection, manufactured by Fresenius Kabi in Lake Zurich, IL 60047. There is a code at the end: 01003652.*
FDA Label Image

Principal Display Panel – 2.2 mL (Vial Label)

Principal Display Panel – 2.2 mL (Vial Label)
This is a description for a prescription drug with the name Temsirolimus. The drug is meant to be injected directly into the bloodstream with a single-use vial containing 22 mL of the medication. It must be refrigerated until use, and should only be administered under the direction of a healthcare professional. The drug contains about 45% dehydrated alcohol. Further usage instructions can be found in the insert. The manufacturer is Fresenius Kabi Lake Zich, located in ILE004T. The code number for the drug is APDRUGSO3]1.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.